Huang Jane - Insider Non-Derivative Transactions at Prelude Therapeutics Inc (PRLD) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jul 4, 2024, Huang Jane's relationship to Prelude Therapeutics Inc (PRLD) is Officer (President, CMO), and currently has 60,662 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other PRLD insiders.

Data Source: SEC.
Huang Jane - Insider Non-Derivative Transactions of PRLD Common Stock
Huang Jane - Insider Non-Derivative Transactions at PRLD
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jul 5, 2024 F -- (Common Stock) 3347 3.6 57315
Jul 5, 2024 M -- (Common Stock) 9375 0 60662
Apr 5, 2024 F -- (Common Stock) 3347 4.74 51287
Apr 5, 2024 M -- (Common Stock) 9375 0 54634
Jan 5, 2024 F -- (Common Stock) 3844 3.77 45259
Jan 5, 2024 M -- (Common Stock) 9375 0 49103
Oct 5, 2023 M -- (Common Stock) 9375 0 39728
Jul 5, 2023 F -- (Common Stock) 3242 4.65 30353
Jul 5, 2023 M -- (Common Stock) 9375 0 33595
Apr 7, 2023 Sell -- (Common Stock) 13280 6.12 24220
Apr 5, 2023 M -- (Common Stock) 37500 0 37500